Who is sponsoring NCT03947541?

NCT03947541 is sponsored by Duke University.

What drugs are being tested in NCT03947541?

Interventions in NCT03947541: Thoracolumbosacral (TLSO) brace, No Bracing.

What condition does NCT03947541 study?

NCT03947541 studies Postoperative Bracing for Spinal Deformity.

Is NCT03947541 still recruiting?

NCT03947541 is currently completed. Last updated 23 February 2022.

Last reviewed 2022-02-23 · How we verify

NCT03947541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Utility of Postoperative Bracing

Completed NA Last updated 23 February 2022

What this trial tests

NA trial testing Thoracolumbosacral (TLSO) brace in Postoperative Bracing for Spinal Deformity in 14 participants. Completed in 30 December 2021.

Timeline

14 May 2019

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	14
Start date	14 May 2019
Primary completion	30 December 2021
Estimated completion	30 December 2021
Sites	1 location across United States

Drugs / interventions tested

Thoracolumbosacral (TLSO) brace
No Bracing

Conditions studied

Postoperative Bracing for Spinal Deformity — all drugs for Postoperative Bracing for Spinal Deformity →

Sponsor

Duke University

Who can join

Adults 18 to 80, any sex, with Postoperative Bracing for Spinal Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is being done to assess if the use of bracing helps improve quality of life of patients that are undergoing a spinal fusion for deformity. If the participant agrees to be in this trial they will be randomly assigned (like the flip of a coin) to receive either brace treatment or non-brace treatment. Regardless of what treatment group the participants are in, they will undergo surgery as planned. After surgery, patients in both groups will be treated per standard of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03947541 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 23 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03947541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing